David Vallerand is Director of Scientific Engagement for customers based in Europe. David’s background is in translational research with an expertise in biological drug development, ranging from establishment of innovative preclinical models to clinical phases. After obtaining his PhD at Roche, he held various positions in biotechnology and pharmacology services companies. He actively participated in the development of PEP-010 and INVAC-1, two promising anticancer drugs currently in clinical development.
